Clinical trials at the National Institutes of Health and at organizations it funds may continue, and patients may still travel to trial sites to participate in research, despite the Trump administration’s restrictions on travel and communications, the acting director of the N.I.H., Dr. Matthew Memoli, said in an email to staff on Monday.
Source link
